mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |